Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Daisy Alapat

Concepts (249)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
28
2024
2990
1.780
Why?
Flow Cytometry
5
2018
472
0.860
Why?
Immunoglobulins
2
2018
80
0.680
Why?
Immunoglobulin kappa-Chains
2
2016
20
0.610
Why?
Bone Marrow
7
2022
360
0.570
Why?
DNA, Neoplasm
1
2018
144
0.550
Why?
Hematopoietic Stem Cell Transplantation
4
2024
580
0.540
Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
90
0.520
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
45
0.500
Why?
Immunoglobulin lambda-Chains
1
2015
14
0.490
Why?
Gene Rearrangement, B-Lymphocyte
1
2015
5
0.470
Why?
Receptors, Antigen, B-Cell
1
2015
6
0.470
Why?
Tumor Microenvironment
4
2024
221
0.450
Why?
Plasma Cells
2
2016
220
0.450
Why?
Neoplasm, Residual
5
2022
161
0.430
Why?
Plasmacytoma
3
2022
42
0.390
Why?
Humans
48
2025
50419
0.380
Why?
Cell Differentiation
1
2015
640
0.380
Why?
Lymphoma, Mantle-Cell
1
2012
14
0.380
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
11
0.380
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2024
112
0.360
Why?
Carcinoembryonic Antigen
1
2011
12
0.360
Why?
Calcitonin
1
2011
30
0.360
Why?
Antigens, CD
1
2012
221
0.350
Why?
Carcinoma
1
2011
137
0.320
Why?
Myogenin
1
2008
4
0.310
Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.310
Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.310
Why?
Middle Aged
18
2025
12579
0.290
Why?
Paraproteinemias
2
2022
71
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
997
0.270
Why?
Neoplasms, Second Primary
2
2019
74
0.260
Why?
Prognosis
7
2024
1974
0.250
Why?
Gene Expression Profiling
3
2016
1020
0.240
Why?
Treatment Outcome
10
2022
5265
0.240
Why?
Pancytopenia
3
2016
38
0.230
Why?
Female
21
2025
27053
0.220
Why?
Male
18
2025
25866
0.220
Why?
Aged
16
2025
9738
0.210
Why?
Gastrointestinal Neoplasms
1
2022
40
0.190
Why?
Embolization, Therapeutic
2
2021
87
0.190
Why?
Neoplasms, Plasma Cell
2
2020
36
0.190
Why?
Thrombocytopenia
1
2022
82
0.180
Why?
Chromosome Deletion
2
2023
134
0.180
Why?
Cryosurgery
1
2021
36
0.180
Why?
Skin Neoplasms
2
2016
492
0.170
Why?
Transplantation, Autologous
4
2024
480
0.170
Why?
Combined Modality Therapy
1
2021
640
0.160
Why?
Phenotype
2
2025
736
0.150
Why?
Ploidies
1
2018
11
0.150
Why?
Hematopoietic Stem Cells
1
2019
197
0.150
Why?
Leukemia, Myeloid, Acute
1
2019
180
0.150
Why?
Kidney Diseases
1
2020
213
0.140
Why?
Herpesvirus 8, Human
1
2019
97
0.140
Why?
Sarcoma, Myeloid
1
2017
20
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
34
0.140
Why?
Immunohistochemistry
3
2016
955
0.140
Why?
Lymph Nodes
2
2019
256
0.140
Why?
Amyloidosis
2
2016
79
0.130
Why?
Cell Cycle
1
2018
227
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
Registries
3
2025
565
0.130
Why?
Skin Diseases, Infectious
1
2016
8
0.130
Why?
Leukemia, Promyelocytic, Acute
1
2016
11
0.130
Why?
Anemia, Aplastic
1
2016
11
0.130
Why?
Adult
9
2025
13561
0.120
Why?
Myeloproliferative Disorders
1
2016
28
0.120
Why?
Electrophoresis, Capillary
1
2015
10
0.120
Why?
In Situ Hybridization
1
2015
66
0.120
Why?
Tumor Suppressor Protein p53
1
2017
212
0.120
Why?
V(D)J Recombination
1
2015
4
0.120
Why?
Immunophenotyping
1
2015
106
0.120
Why?
RNA, Messenger
2
2015
1085
0.120
Why?
Diagnosis, Differential
3
2016
1029
0.120
Why?
Fatal Outcome
1
2015
197
0.120
Why?
Bone Marrow Transplantation
2
2022
135
0.110
Why?
Immunoglobulin Light Chains
1
2015
83
0.110
Why?
Prealbumin
1
2014
21
0.110
Why?
Bone Marrow Neoplasms
1
2014
13
0.110
Why?
Neoplasm Proteins
1
2016
320
0.110
Why?
Polymerase Chain Reaction
1
2015
447
0.110
Why?
Hodgkin Disease
1
2014
45
0.110
Why?
Parvoviridae Infections
1
2013
20
0.100
Why?
Parvovirus B19, Human
1
2013
17
0.100
Why?
Partial Thromboplastin Time
1
2012
12
0.100
Why?
Prothrombin Time
1
2012
18
0.100
Why?
Cardiomyopathies
1
2014
119
0.100
Why?
Afibrinogenemia
1
2012
5
0.100
Why?
Predictive Value of Tests
1
2015
924
0.100
Why?
Immunoglobulins, Intravenous
1
2013
64
0.100
Why?
Plasma Exchange
1
2012
25
0.100
Why?
Retroperitoneal Neoplasms
1
2012
17
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2016
831
0.100
Why?
Glycoproteins
1
2012
116
0.100
Why?
Precursor Cells, B-Lymphoid
1
2012
8
0.100
Why?
Histoplasma
1
2011
27
0.090
Why?
Longitudinal Studies
2
2024
732
0.090
Why?
Antigens, Fungal
1
2011
25
0.090
Why?
Immunoenzyme Techniques
1
2011
140
0.090
Why?
Hepatitis C
1
2012
76
0.090
Why?
Histoplasmosis
1
2011
50
0.090
Why?
In Situ Hybridization, Fluorescence
3
2023
231
0.090
Why?
Carcinoma, Neuroendocrine
1
2011
22
0.090
Why?
Dose-Response Relationship, Drug
2
2016
1369
0.080
Why?
Splenic Neoplasms
1
2009
2
0.080
Why?
Disease Progression
3
2022
825
0.080
Why?
Gene Expression
1
2012
605
0.080
Why?
Thyroid Neoplasms
1
2011
109
0.080
Why?
Myelodysplastic Syndromes
1
2009
78
0.080
Why?
Retrospective Studies
4
2024
6274
0.080
Why?
Mutagenesis, Site-Directed
1
2008
96
0.080
Why?
Hemangioma
1
2009
83
0.080
Why?
Aged, 80 and over
4
2019
3233
0.070
Why?
HIV Infections
1
2012
347
0.070
Why?
Tomography, X-Ray Computed
3
2023
1163
0.070
Why?
Survival Analysis
2
2021
658
0.070
Why?
Cells, Cultured
2
2008
1563
0.070
Why?
Protein Processing, Post-Translational
1
2008
155
0.070
Why?
Stem Cell Transplantation
2
2022
179
0.070
Why?
Adolescent
2
2025
6453
0.070
Why?
Graft vs Host Disease
1
2007
85
0.070
Why?
Positron-Emission Tomography
2
2021
290
0.070
Why?
Muscle Proteins
1
2008
320
0.060
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
34
0.060
Why?
Semaphorin-3A
1
2004
2
0.060
Why?
Antineoplastic Agents
1
2013
1165
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
90
0.060
Why?
Nerve Degeneration
1
2004
25
0.060
Why?
Acid Anhydride Hydrolases
1
2004
14
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2004
49
0.060
Why?
Mitogen-Activated Protein Kinase 1
1
2004
50
0.060
Why?
Muscle, Smooth, Vascular
1
2005
130
0.060
Why?
Imidazoles
1
2005
125
0.060
Why?
Ferritins
1
2024
30
0.050
Why?
Killer Cells, Natural
1
2024
107
0.050
Why?
Gene Expression Regulation
1
2008
948
0.050
Why?
Pyridines
1
2005
130
0.050
Why?
Cost of Illness
1
2024
115
0.050
Why?
Pyrimidines
1
2005
187
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
127
0.050
Why?
Enzyme Inhibitors
1
2005
369
0.050
Why?
Adrenal Cortex Hormones
1
2023
102
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Hippocampus
1
2004
221
0.050
Why?
Case-Control Studies
2
2019
1152
0.050
Why?
Cohort Studies
2
2020
1451
0.050
Why?
Chromosome Aberrations
1
2023
279
0.050
Why?
Dexamethasone
1
2024
431
0.050
Why?
Mediastinum
1
2021
21
0.050
Why?
Gastrointestinal Tract
1
2022
103
0.050
Why?
Fever
1
2022
112
0.050
Why?
Neurons
1
2004
445
0.050
Why?
Vincristine
1
2021
82
0.050
Why?
T-Lymphocytes
1
2023
325
0.050
Why?
Axilla
1
2021
92
0.050
Why?
Prednisone
1
2021
101
0.040
Why?
Pelvis
1
2021
66
0.040
Why?
Alzheimer Disease
1
2004
316
0.040
Why?
Signal Transduction
2
2004
1608
0.040
Why?
Time Factors
2
2017
2933
0.040
Why?
Cyclophosphamide
1
2021
168
0.040
Why?
Radiopharmaceuticals
1
2021
202
0.040
Why?
Fluorodeoxyglucose F18
1
2021
187
0.040
Why?
Tumor Burden
1
2020
130
0.040
Why?
Mice
3
2023
5659
0.040
Why?
Hospitalization
1
2024
677
0.040
Why?
Antibodies, Monoclonal
1
2023
460
0.040
Why?
Doxorubicin
1
2021
235
0.040
Why?
False Negative Reactions
1
2019
29
0.040
Why?
Cell Line, Tumor
1
2023
1393
0.040
Why?
Herpesvirus 4, Human
1
2019
37
0.040
Why?
Epstein-Barr Virus Infections
1
2019
30
0.040
Why?
Phosphorylation
3
2005
520
0.040
Why?
Herpesviridae Infections
1
2019
54
0.040
Why?
Genome, Viral
1
2019
73
0.040
Why?
DNA, Viral
1
2019
134
0.040
Why?
Virus Diseases
1
2019
42
0.040
Why?
Follow-Up Studies
1
2024
2231
0.040
Why?
Neoplasm Recurrence, Local
1
2022
622
0.040
Why?
Liver
1
2022
1126
0.030
Why?
Scleromyxedema
1
2016
4
0.030
Why?
Schnitzler Syndrome
1
2016
4
0.030
Why?
Cryoglobulinemia
1
2016
13
0.030
Why?
Xanthomatosis
1
2016
10
0.030
Why?
Asymptomatic Diseases
1
2016
38
0.030
Why?
POEMS Syndrome
1
2016
32
0.030
Why?
Melphalan
1
2016
177
0.030
Why?
Young Adult
1
2025
4075
0.030
Why?
Disease-Free Survival
1
2016
439
0.030
Why?
Animals
3
2023
13063
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
179
0.030
Why?
Reed-Sternberg Cells
1
2014
2
0.030
Why?
HIV Seronegativity
1
2014
3
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Thalidomide
1
2016
375
0.030
Why?
Fusion Proteins, bcr-abl
1
2014
17
0.030
Why?
Cell Division
2
2005
292
0.030
Why?
Mutation
1
2019
1275
0.030
Why?
Heterozygote
1
2014
83
0.030
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
45
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
568
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
400
0.030
Why?
Remission Induction
1
2014
208
0.030
Why?
Fibrinogen
1
2012
33
0.030
Why?
Risk Assessment
1
2017
1268
0.020
Why?
Blood Coagulation
1
2012
59
0.020
Why?
Survival Rate
1
2015
906
0.020
Why?
Neoplasm Staging
1
2015
738
0.020
Why?
Reference Values
1
2012
302
0.020
Why?
Biopsy
1
2014
588
0.020
Why?
Antibodies, Fungal
1
2011
4
0.020
Why?
Mycological Typing Techniques
1
2011
3
0.020
Why?
Cross Reactions
1
2011
40
0.020
Why?
Lung Diseases, Fungal
1
2011
32
0.020
Why?
Immunocompromised Host
1
2011
119
0.020
Why?
Splenectomy
1
2009
34
0.020
Why?
Severity of Illness Index
1
2012
976
0.020
Why?
Sensitivity and Specificity
1
2011
855
0.020
Why?
Blood Transfusion
1
2009
123
0.020
Why?
Transplantation, Isogeneic
1
2007
2
0.020
Why?
Laparoscopy
1
2009
172
0.020
Why?
Mice, Inbred C3H
1
2007
85
0.020
Why?
Cyclosporine
1
2007
67
0.020
Why?
Mice, SCID
1
2007
171
0.020
Why?
Magnetic Resonance Imaging
1
2014
1546
0.020
Why?
Models, Animal
1
2007
225
0.020
Why?
Immunosuppressive Agents
1
2007
227
0.020
Why?
Macromolecular Substances
1
2004
36
0.010
Why?
Physical Chromosome Mapping
1
2004
8
0.010
Why?
tau Proteins
1
2004
29
0.010
Why?
Genetic Complementation Test
1
2004
47
0.010
Why?
Epitopes
1
2004
60
0.010
Why?
Epidermal Growth Factor
1
2004
33
0.010
Why?
Cricetulus
1
2004
106
0.010
Why?
Catalytic Domain
1
2004
57
0.010
Why?
Microtubule-Associated Proteins
1
2004
66
0.010
Why?
Mutagenesis
1
2004
58
0.010
Why?
Cricetinae
1
2004
207
0.010
Why?
Cloning, Molecular
1
2004
190
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2004
102
0.010
Why?
Receptors, Cell Surface
1
2004
117
0.010
Why?
RNA
1
2004
164
0.010
Why?
Cell Survival
1
2005
587
0.010
Why?
Amino Acid Sequence
1
2004
575
0.010
Why?
Molecular Sequence Data
1
2004
760
0.010
Why?
Nerve Tissue Proteins
1
2004
191
0.010
Why?
Mice, Inbred C57BL
1
2007
1796
0.010
Why?
Cell Line
1
2004
997
0.010
Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description